摘要:
Nouvelles formes de gp160, sensiblement non clivables, et formulations de vaccins contenant de la gp160 ou un de ses dérivés, comportant un adjuvant 3D-Mpl. Les compositions s'utilisent pour le traitement immunotherapeutique et immunoprophylactique des infections VIH.
摘要:
Immediate early HSV-2 viral protein ICP27 recognised by cytolytic T-lymphocyte (CTL) cells in humans, methods for preparation thereof and use in vaccine.
摘要:
Novel herpes simplex (HSV) vaccine formulations are provided. These comprise HSV glycoprotein gD or immunological fragments in conjunction with 3 Deacylated monophosphoryl lipid A.
摘要:
On décrit de nouvelles formulations de vaccin contre le virus de l'herpès simplex (HSV) comprenant la glycoprotéine gD du HSV ou des fragments immunologiques conjugués avec le lipide A de monophosphoryle 3-déacylé.
摘要:
The present invention provides vaccine compositions comprising 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccines compositions are potent inducers of CTL and gamma IFN responses.
摘要:
Novel herpes simplex (HSV) vaccine formulations are provided. These comprise HSV glycoprotein gD or immunological fragments in conjunction with 3 Deacylated monophosphoryl lipid A.
摘要:
The present invention provides vaccine compositions comprising 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccines compositions are potent inducers of CTL and gamma IFN responses.